Phase 1 Start
ONC: Phase 1 Start: A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and
September 4, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 4, 2026
- Company
- BeOne Medicines Ltd. (ONC)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 1 Start~month
Phase 1 Start: A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and
- Company
- BeOne Medicines Ltd. (ONC)
- Indication
- Advanced Solid Tumor; Metastatic Solid Tumor; RAS Mutation